基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Summary
Professor Walters's principal interests are the Molecular and cellular function of the small intestine -- in particular how the development and differentiation of the mucosal epithelial cells affects nutrient transport. This include the effects of inflammatory diseases of the intestine causing malabsorption, such as coeliac disease and Crohn's disease, and the changes in gene expression during active disease and the repair process.
Recent research has resulted in a paradigm shift in the understanding of chronic Bile Acid Diarrhoea (also known as Bile Salt Malabsorption or Bile Acid Malabsorption). Rather than malabsorption, underproduction of the ileal hormone FGF19 results in excessive hepatic bile acid synthesis, exceeding the normal capacity for absorption. A review showed that about one-third of patients with IBS-D have BAD and this represents around 1% of the adult population.
FGF19 production in the ileum is stimulated by bile acids and this is deficient in patients with BAD. Blood levels of this hormone are low. Drugs known as FXR agonists (obeticholic acid is the first in class) are able to stimulate production of FGF19 and give symptomatic improvement.
Prof. Walters aims to increase the awareness of BAD and to develop new treatments that are well tolerated.
Professor Walters's principal interests are the Molecular and cellular function of the small intestine -- in particular how the development and differentiation of the mucosal epithelial cells affects nutrient transport. This include the effects of inflammatory diseases of the intestine causing malabsorption, such as coeliac disease and Crohn's disease, and the changes in gene expression during active disease and the repair process.
Recent research has resulted in a paradigm shift in the understanding of chronic Bile Acid Diarrhoea (also known as Bile Salt Malabsorption or Bile Acid Malabsorption). Rather than malabsorption, underproduction of the ileal hormone FGF19 results in excessive hepatic bile acid synthesis, exceeding the normal capacity for absorption. A review showed that about one-third of patients with IBS-D have BAD and this represents around 1% of the adult population.
FGF19 production in the ileum is stimulated by bile acids and this is deficient in patients with BAD. Blood levels of this hormone are low. Drugs known as FXR agonists (obeticholic acid is the first in class) are able to stimulate production of FGF19 and give symptomatic improvement.
Prof. Walters aims to increase the awareness of BAD and to develop new treatments that are well tolerated.
Research Interests
Papers共 216 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Christopher Bannon,Julian R. Walters, Robin C. Spiller,Alexander C. Ford,Keith Burling,Petra Verdino, Jonathan M. Wilson,Frank Reimann,Fiona Gribble
Gastroenterologyno. 5 (2024): S-1381
Gastroenterologyno. 6 (2023): S-787
GASTROENTEROLOGYno. 6 (2023): S787-S787
Cited0Views0Bibtex
0
0
medRxiv (Cold Spring Harbor Laboratory) (2022)
medrxiv(2022)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn